Deal Street Powered By:

South Africa’s Rand Pharm Secures Investment From Vumela Fund
South Africa’s Rand Pharm Secures Investment From Vumela Fund

Rand Pharmaceutical Distributors (Rand Pharm), a South African pharmaceutical distributor, has received funding from The Vumela Fund,  founded by FNB Business and Edge Growth.

The investment is targeted at supporting an acquisition that will boost capacity and create new partnerships that will sustain long-term growth.

Rand Pharm has a single warehouse that serves the independent retail pharmacy industry, as well as expanding markets in the townships, by dispensing to doctors, hospitals, and clinics. They offer a complete range of generic medicine from pharmaceutical companies including Aspen, Adcock Ingram, Cipla, Sun Pharma, Pharmadynamics, Biotech Labs and more.

Popular

Annual Membership

$60

(billed annually)

Access To 12-Month WT Membership

Access To WT's Conferences & Events

Access To All WT's Research Reports On Africa

Access To Podcasts, Video Content & Recordings

Access To All Premium Newsletters

Unlimited Access To WT's Content Archive

Subscribe Now